Inventor · disambiguated record
Petra Simon
Also filed as: SIMON PETRA
11 granted patents·4 pending applications·33 citations·filing 2011–2023
86Inventor score
Top patents by PatentIndex Score
15 records- 0194US10117918B2Antigen-specific T cell receptors and T cell epitopesSAHIN UGUR·Filed 2016·Granted Nov 6, 2018·18 cites·13 claims
- 0284US9586997B2Antigen-specific T cell receptors and T cell epitopesSAHIN UGUR·Filed 2011·Granted Mar 7, 2017·6 cites·12 claims
- 0380US12410221B2Tumor antigens for determining cancer therapyBioNTech SE·Filed 2023·Granted Sep 9, 2025·0 cites·13 claims
- 0480US11628209B2Tumor antigens for determining cancer therapyBIONTECH AG·Filed 2018·Granted Apr 18, 2023·1 cites·15 claims
- 0579US10370423B2Claudin-6-specific immunoreceptors and T cell epitopesBIONTECH CELL & GENE THERAPIES GMBH·Filed 2015·Granted Aug 6, 2019·4 cites·8 claims
- 0676US10188712B2Tumor antigens for determining cancer therapyBIONTECH AG·Filed 2014·Granted Jan 29, 2019·3 cites·7 claims
- 0774US2022288180A1Antigen-specific t cell receptors and t cell epitopesBIONTECH CELL & GENE THERAPIES GMBH·Filed 2022·Application pending·0 cites
- 0870US2023119334A1Antigen receptors and uses thereofBIONTECH CELL & GENE THERAPIES GMBH·Filed 2022·Application pending·0 cites
- 0969US11311611B2Antigen-specific T cell receptors and T cell epitopesBIONTECH CELL & GENE THERAPIES GMBH·Filed 2018·Granted Apr 26, 2022·0 cites·16 claims
- 1069US10550430B2Method and kit for determining whether a subject shows an immune responseBIONTECH AG·Filed 2014·Granted Feb 4, 2020·1 cites·20 claims
- 1167US11345731B2Claudin-6-specific immunoreceptors and t cell epitopesBIONTECH CELL & GENE THERAPIES GMBH·Filed 2019·Granted May 31, 2022·0 cites·12 claims
- 1266US2022033461A1Antigen receptors and uses thereofBIONTECH CELL & GENE THERAPIES GMBH·Filed 2021·Application pending·0 cites
- 1360US12186275B2Enhancing the effect of CAR-engineered T cells by means of nucleic acid vaccinationBIONTECH CELL & GENE THERAPIES GMBH·Filed 2020·Granted Jan 7, 2025·0 cites·29 claims
- 1454US10799534B2Enhancing the effect of car-engineered T cells by means of nucleic acid vaccinationBIONTECH CELL & GENE THERAPIES GMBH·Filed 2016·Granted Oct 13, 2020·0 cites·18 claims
- 1548US2018282390A1Antigen receptors and uses thereofBIONTECH CELL & GENE THERAPIES GMBH·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Petra Simon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →